1. Home
  2. PRGO vs PGEN Comparison

PRGO vs PGEN Comparison

Compare PRGO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$10.25

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$5.54

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRGO
PGEN
Founded
1887
1998
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
PRGO
PGEN
Price
$10.25
$5.54
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$19.33
$8.33
AVG Volume (30 Days)
3.1M
4.0M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
10.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$800,000.00
$230,981,000.00
Revenue This Year
N/A
$1,115.92
Revenue Next Year
$1.02
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.23
$1.57
52 Week High
$28.22
$6.04

Technical Indicators

Market Signals
Indicator
PRGO
PGEN
Relative Strength Index (RSI) 47.76 58.35
Support Level $9.42 $3.96
Resistance Level $11.72 $6.04
Average True Range (ATR) 0.48 0.28
MACD -0.01 -0.01
Stochastic Oscillator 31.94 82.95

Price Performance

Historical Comparison
PRGO
PGEN

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: